Skip to main content
Fig. 6 | Pediatric Rheumatology

Fig. 6

From: Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)

Fig. 6

Mean change from baseline in C-reactive protein (mg/dL) across patients with NNS/CANDLE, SAVI, or AGS. AGS = Aicardi-Goutières syndrome; IFN = interferon; LOCF = last observation carried forward; NNS/CANDLE = Nakajo-Nishimura syndrome/chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature; SAVI = STING-associated vasculopathy with onset during infancy; STING = stimulator of interferon genes. LOCF data were used for imputation

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096